Earlier this month, CBSA participated in PASTEUR Advocacy Day, joining Biotechnology Innovation Organization (BIO) and other organizations, including Infectious Diseases Society of America, Cystic Fibrosis Foundation, Partnership to Fight Infectious Disease, and The Pew Charitable Trusts, in raising awareness about the public health crisis of antimicrobial resistance (AMR). We encouraged policymakers to take action on the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.
The PASTEUR Act establishes a delinked subscription program to encourage innovative antimicrobial drug development targeting the most threatening infections, to improve the appropriate use of antibiotics, and to ensure domestic availability when needed.
As superbugs grow stronger and the effectiveness of current antibiotics fades, many common medical procedures could become far more dangerous. CBSA urges Congress to protect modern medicine by taking action to pass the PASTEUR Act.
We thank…
Click here to view original post
